世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

動物用サプリメント市場(サプリメントタイプ:サプリメントタイプ:酸化防止剤、ビタミン、タンパク質/アミノ酸、酵素、プロバイオティクス、必須脂肪酸、その他;動物タイプ:コンパニオンアニマルおよび家畜)-世界産業分析、規模、シェア、成長、動向、予測、2023-2031年


Veterinary Supplements Market (Supplement Type: Antioxidants, Vitamins, Proteins/Amino acids, Enzymes, Probiotics, Essential Fatty Acids, and Others; Animal Type: Companion Animals and Livestock) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

動物用サプリメント市場 - レポートの範囲 TMR社の動物用サプリメントの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2023年8月7日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
260 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

動物用サプリメント市場 - レポートの範囲
TMR社の動物用サプリメントの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の動物用サプリメント市場の収益を提供しています。また、2023年から2031年までの世界の動物用サプリメント市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されています。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、動物用サプリメント市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照した。

二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれる。アナリストは、世界の動物用サプリメント市場の様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用した。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、このレポートは、世界の動物用サプリメント市場における競争力学の変化に光を投げかけています。これらは、既存の市場プレーヤーだけでなく、世界の動物用サプリメント市場への参入に関心のある事業体にとっても貴重なツールとなります。

本レポートでは、世界の動物用サプリメント市場の競争環境について掘り下げています。世界の動物用サプリメント市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性の観点からプロファイリングされている。会社概要、財務状況、最近の動向、SWOTは、このレポートで紹介されている世界の動物用サプリメント市場のプレーヤーの属性です。

世界の動物用サプリメント市場レポートで回答された主な質問
- 予測期間中、全地域で動物用サプリメントが生み出す売上/収益は?
- 世界の動物用サプリメント市場における機会は何か?
- 市場における主な促進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大する地域市場はどこか?
- 2031年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは?
- 世界市場で事業を展開する各企業の市場ポジションは?

動物用サプリメント市場 - 調査目的と調査アプローチ
世界の動物用サプリメント市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳細に説明しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。

本レポートでは、世界の動物用サプリメント市場を製品、エンドユーザー、地域の観点から分析している。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載している。このような貴重な洞察は、市場関係者が世界の動物用サプリメント市場への投資のための情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Supplements Market
4. Market Overview
    4.1. Introduction
        4.1.1. Supplement Type Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Insights on The impact of e-commerce on the pet sales landscape
    5.2. U.S. pet ownership statistics
    5.3. Regulatory Scenario by Region/Globally
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Supplement Type, 2017-2031
        6.3.1. Antioxidants
        6.3.2. Vitamins
        6.3.3. Proteins/Amino acids
        6.3.4. Enzymes
        6.3.5. Probiotics
        6.3.6. Essential Fatty Acids
        6.3.7. Others
    6.4. Market Attractiveness Analysis, by Supplement Type
7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Animal Type, 2017-2031
        7.3.1. Companion Animals
            7.3.1.1. Dog
            7.3.1.2. Cat
        7.3.2. Livestock
            7.3.2.1. Cattle
            7.3.2.2. Horse
            7.3.2.3. Sheep
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031
        8.3.1. Joint Health Support
        8.3.2. Calming/Stress/Anxiety
        8.3.3. Digestive Health
        8.3.4. Energy & Electrolytes
        8.3.5. Immunity Support
        8.3.6. Skin & Coat Health
        8.3.7. Others
    8.4. Market Attractiveness Analysis, by Application/Benefit Area
9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by Dosage Form, 2017-2031
        9.3.1. Pills & Tablets
        9.3.2. Chewables
        9.3.3. Powders
        9.3.4. Others
    9.4. Market Attractiveness Analysis, by Dosage Form
10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel
    10.1. Introduction & Definition
    10.2. Key Findings/Developments
    10.3. Market Value Forecast, by Distribution Channel, 2017-2031
        10.3.1. Small Animal Veterinary
        10.3.2. Large Animal Veterinary
        10.3.3. Mixed Animal Veterinary
        10.3.4. Retail Stores
        10.3.5. Drug Stores
        10.3.6. Online Sales
    10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Veterinary Supplements Market Analysis and Forecast, by Region
    11.1. Key Findings
    11.2. Market Value Forecast, by Region, 2017-2031
        11.2.1. North America
        11.2.2. Europe
        11.2.3. Asia Pacific
        11.2.4. Latin America
        11.2.5. Middle East & Africa
    11.3. Market Attractiveness Analysis, by Region
12. North America Veterinary Supplements Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Supplement Type, 2017-2031
        12.2.1. Antioxidants
        12.2.2. Vitamins
        12.2.3. Proteins/Amino acids
        12.2.4. Enzymes
        12.2.5. Probiotics
        12.2.6. Essential Fatty Acids
        12.2.7. Others
    12.3. Market Value Forecast, by Animal Type, 2017-2031
        12.3.1. Companion Animals
            12.3.1.1. Dog
            12.3.1.2. Cat
        12.3.2. Livestock
            12.3.2.1. Cattle
            12.3.2.2. Horse
            12.3.2.3. Sheep
        12.3.3. Others
    12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        12.4.1. Joint Health Support
        12.4.2. Calming/Stress/Anxiety
        12.4.3. Digestive Health
        12.4.4. Energy & Electrolytes
        12.4.5. Immunity Support
        12.4.6. Skin & Coat Health
        12.4.7. Others
    12.5. Market Value Forecast, by Dosage Form, 2017-2031
        12.5.1. Pills & Tablets
        12.5.2. Chewables
        12.5.3. Powders
        12.5.4. Others
    12.6. Market Value Forecast, by Distribution Channel, 2017-2031
        12.6.1. Small Animal Veterinary
        12.6.2. Large Animal Veterinary
        12.6.3. Mixed Animal Veterinary
        12.6.4. Retail Stores
        12.6.5. Drug Stores
        12.6.6. Online Sales
    12.7. Market Value Forecast, by Country, 2017-2031
        12.7.1. U.S.
        12.7.2. Canada
    12.8. Market Attractiveness Analysis
        12.8.1. By Supplement Type
        12.8.2. By Animal Type
        12.8.3. By Application/Benefit Area
        12.8.4. By Dosage Form
        12.8.5. By Distribution Channel
        12.8.6. By Country
13. Europe Veterinary Supplements Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Supplement Type, 2017-2031
        13.2.1. Antioxidants
        13.2.2. Vitamins
        13.2.3. Proteins/Amino acids
        13.2.4. Enzymes
        13.2.5. Probiotics
        13.2.6. Essential Fatty Acids
        13.2.7. Others
    13.3. Market Value Forecast, by Animal Type, 2017-2031
        13.3.1. Companion Animals
            13.3.1.1. Dog
            13.3.1.2. Cat
        13.3.2. Livestock
            13.3.2.1. Cattle
            13.3.2.2. Horse
            13.3.2.3. Sheep
        13.3.3. Others
    13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        13.4.1. Joint Health Support
        13.4.2. Calming/Stress/Anxiety
        13.4.3. Digestive Health
        13.4.4. Energy & Electrolytes
        13.4.5. Immunity Support
        13.4.6. Skin & Coat Health
        13.4.7. Others
    13.5. Market Value Forecast, by Dosage Form, 2017-2031
        13.5.1. Pills & Tablets
        13.5.2. Chewables
        13.5.3. Powders
        13.5.4. Others
    13.6. Market Value Forecast, by Distribution Channel, 2017-2031
        13.6.1. Small Animal Veterinary
        13.6.2. Large Animal Veterinary
        13.6.3. Mixed Animal Veterinary
        13.6.4. Retail Stores
        13.6.5. Drug Stores
        13.6.6. Online Sales
    13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.7.1. Germany
        13.7.2. U.K.
        13.7.3. France
        13.7.4. Italy
        13.7.5. Spain
        13.7.6. Rest of Europe
    13.8. Market Attractiveness Analysis
        13.8.1. By Supplement Type
        13.8.2. By Animal Type
        13.8.3. By Application/Benefit Area
        13.8.4. By Dosage Form
        13.8.5. By Distribution Channel
        13.8.6. By Country/Sub-region
14. Asia Pacific Veterinary Supplements Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Supplement Type, 2017-2031
        14.2.1. Antioxidants
        14.2.2. Vitamins
        14.2.3. Proteins/Amino acids
        14.2.4. Enzymes
        14.2.5. Probiotics
        14.2.6. Essential Fatty Acids
        14.2.7. Others
    14.3. Market Value Forecast, by Animal Type, 2017-2031
        14.3.1. Companion Animals
            14.3.1.1. Dog
            14.3.1.2. Cat
        14.3.2. Livestock
            14.3.2.1. Cattle
            14.3.2.2. Horse
            14.3.2.3. Sheep
        14.3.3. Others
    14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        14.4.1. Joint Health Support
        14.4.2. Calming/Stress/Anxiety
        14.4.3. Digestive Health
        14.4.4. Energy & Electrolytes
        14.4.5. Immunity Support
        14.4.6. Skin & Coat Health
        14.4.7. Others
    14.5. Market Value Forecast, by Dosage Form, 2017-2031
        14.5.1. Pills & Tablets
        14.5.2. Chewables
        14.5.3. Powders
        14.5.4. Others
    14.6. Market Value Forecast, by Distribution Channel, 2017-2031
        14.6.1. Small Animal Veterinary
        14.6.2. Large Animal Veterinary
        14.6.3. Mixed Animal Veterinary
        14.6.4. Retail Stores
        14.6.5. Drug Stores
        14.6.6. Online Sales
    14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.7.1. China
        14.7.2. Japan
        14.7.3. India
        14.7.4. Australia & New Zealand
        14.7.5. Rest of Asia Pacific
    14.8. Market Attractiveness Analysis
        14.8.1. By Supplement Type
        14.8.2. By Animal Type
        14.8.3. By Application/Benefit Area
        14.8.4. By Dosage Form
        14.8.5. By Distribution Channel
        14.8.6. By Country/Sub-region
15. Latin America Veterinary Supplements Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Supplement Type, 2017-2031
        15.2.1. Antioxidants
        15.2.2. Vitamins
        15.2.3. Proteins/Amino acids
        15.2.4. Enzymes
        15.2.5. Probiotics
        15.2.6. Essential Fatty Acids
        15.2.7. Others
    15.3. Market Value Forecast, by Animal Type, 2017-2031
        15.3.1. Companion Animals
            15.3.1.1. Dog
            15.3.1.2. Cat
        15.3.2. Livestock
            15.3.2.1. Cattle
            15.3.2.2. Horse
            15.3.2.3. Sheep
        15.3.3. Others
    15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        15.4.1. Joint Health Support
        15.4.2. Calming/Stress/Anxiety
        15.4.3. Digestive Health
        15.4.4. Energy & Electrolytes
        15.4.5. Immunity Support
        15.4.6. Skin & Coat Health
        15.4.7. Others
    15.5. Market Value Forecast, by Dosage Form, 2017-2031
        15.5.1. Pills & Tablets
        15.5.2. Chewables
        15.5.3. Powders
        15.5.4. Others
    15.6. Market Value Forecast, by Distribution Channel, 2017-2031
        15.6.1. Small Animal Veterinary
        15.6.2. Large Animal Veterinary
        15.6.3. Mixed Animal Veterinary
        15.6.4. Retail Stores
        15.6.5. Drug Stores
        15.6.6. Online Sales
    15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.7.1. Brazil
        15.7.2. Mexico
        15.7.3. Rest of Latin America
    15.8. Market Attractiveness Analysis
        15.8.1. By Supplement Type
        15.8.2. By Animal Type
        15.8.3. By Application/Benefit Area
        15.8.4. By Dosage Form
        15.8.5. By Distribution Channel
        15.8.6. By Country/Sub-region
16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast
    16.1. Introduction
        16.1.1. Key Findings
    16.2. Market Value Forecast, by Supplement Type, 2017-2031
        16.2.1. Antioxidants
        16.2.2. Vitamins
        16.2.3. Proteins/Amino acids
        16.2.4. Enzymes
        16.2.5. Probiotics
        16.2.6. Essential Fatty Acids
        16.2.7. Others
    16.3. Market Value Forecast, by Animal Type, 2017-2031
        16.3.1. Companion Animals
            16.3.1.1. Dog
            16.3.1.2. Cat
        16.3.2. Livestock
            16.3.2.1. Cattle
            16.3.2.2. Horse
            16.3.2.3. Sheep
        16.3.3. Others
    16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        16.4.1. Joint Health Support
        16.4.2. Calming/Stress/Anxiety
        16.4.3. Digestive Health
        16.4.4. Energy & Electrolytes
        16.4.5. Immunity Support
        16.4.6. Skin & Coat Health
        16.4.7. Others
    16.5. Market Value Forecast, by Dosage Form, 2017-2031
        16.5.1. Pills & Tablets
        16.5.2. Chewables
        16.5.3. Powders
        16.5.4. Others
    16.6. Market Value Forecast, by Distribution Channel, 2017-2031
        16.6.1. Small Animal Veterinary
        16.6.2. Large Animal Veterinary
        16.6.3. Mixed Animal Veterinary
        16.6.4. Retail Stores
        16.6.5. Drug Stores
        16.6.6. Online Sales
    16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        16.7.1. GCC Countries
        16.7.2. South Africa
        16.7.3. Rest of Middle East & Africa
    16.8. Market Attractiveness Analysis
        16.8.1. By Supplement Type
        16.8.2. By Animal Type
        16.8.3. By Application/Benefit Area
        16.8.4. By Dosage Form
        16.8.5. By Distribution Channel
        16.8.6. By Country/Sub-region
17. Competition Landscape
    17.1. Market Player - Competition Matrix (by tier and size of companies)
    17.2. Market Share Analysis, by Company, 2022
    17.3. Company Profiles
        17.3.1. Zoetis
            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.1.2. Product Portfolio
            17.3.1.3. Financial Overview
            17.3.1.4. SWOT Analysis
            17.3.1.5. Strategic Overview
        17.3.2. Ceva Sante Animale
            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2.2. Product Portfolio
            17.3.2.3. Financial Overview
            17.3.2.4. SWOT Analysis
            17.3.2.5. Strategic Overview
        17.3.3. Elanco Animal Health
            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.3.2. Product Portfolio
            17.3.3.3. Financial Overview
            17.3.3.4. SWOT Analysis
            17.3.3.5. Strategic Overview
        17.3.4. Vetoquinol S.A.
            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.4.2. Product Portfolio
            17.3.4.3. Financial Overview
            17.3.4.4. SWOT Analysis
            17.3.4.5. Strategic Overview
        17.3.5. Dechra Pharmaceuticals plc
            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.5.2. Product Portfolio
            17.3.5.3. Financial Overview
            17.3.5.4. SWOT Analysis
            17.3.5.5. Strategic Overview
        17.3.6. Merck Animal Health
            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.6.2. Product Portfolio
            17.3.6.3. Financial Overview
            17.3.6.4. SWOT Analysis
            17.3.6.5. Strategic Overview
        17.3.7. Virbac S.A.
            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.7.2. Product Portfolio
            17.3.7.3. Financial Overview
            17.3.7.4. SWOT Analysis
            17.3.7.5. Strategic Overview
        17.3.8. Boehringer Ingelheim
            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.8.2. Product Portfolio
            17.3.8.3. Financial Overview
            17.3.8.4. SWOT Analysis
            17.3.8.5. Strategic Overview
        17.3.9. Norbrook Laboratories Limited
            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.9.2. Product Portfolio
            17.3.9.3. Financial Overview
            17.3.9.4. SWOT Analysis
            17.3.9.5. Strategic Overview
        17.3.10. Hester Biosciences Limited
            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.10.2. Product Portfolio
            17.3.10.3. Financial Overview
            17.3.10.4. SWOT Analysis
            17.3.10.5. Strategic Overview
        17.3.11. Merial Animal Health Limited
            17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.11.2. Product Portfolio
            17.3.11.3. Financial Overview
            17.3.11.4. SWOT Analysis
            17.3.11.5. Strategic Overview
        17.3.12. Novartis Animal Health, Inc.
            17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.12.2. Product Portfolio
            17.3.12.3. Financial Overview
            17.3.12.4. SWOT Analysis
            17.3.12.5. Strategic Overview
        17.3.13. Nutreco N.V.
            17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.13.2. Product Portfolio
            17.3.13.3. Financial Overview
            17.3.13.4. SWOT Analysis
            17.3.13.5. Strategic Overview
        17.3.14. Ouro Fino Saúde Animal
            17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.14.2. Product Portfolio
            17.3.14.3. Financial Overview
            17.3.14.4. SWOT Analysis
            17.3.14.5. Strategic Overview

 

ページTOPに戻る


 

Summary

Veterinary Supplements Market – Scope of Report
TMR’s report on the global veterinary supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global veterinary supplements market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary supplements market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary supplements market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary supplements market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary supplements market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary supplements market.

The report delves into the competitive landscape of the global veterinary supplements market. Key players operating in the global veterinary supplements market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary supplements market profiled in this report.

Key Questions Answered in Global Veterinary Supplements Market Report
• What is the sales/revenue generated by veterinary supplements across all regions during the forecast period?
• What are the opportunities in the global veterinary supplements market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Veterinary Supplements Market – Research Objectives and Research Approach
The comprehensive report on the global veterinary supplements market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary supplements market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary supplements market.



ページTOPに戻る


Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Supplements Market
4. Market Overview
    4.1. Introduction
        4.1.1. Supplement Type Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Insights on The impact of e-commerce on the pet sales landscape
    5.2. U.S. pet ownership statistics
    5.3. Regulatory Scenario by Region/Globally
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Supplement Type, 2017-2031
        6.3.1. Antioxidants
        6.3.2. Vitamins
        6.3.3. Proteins/Amino acids
        6.3.4. Enzymes
        6.3.5. Probiotics
        6.3.6. Essential Fatty Acids
        6.3.7. Others
    6.4. Market Attractiveness Analysis, by Supplement Type
7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Animal Type, 2017-2031
        7.3.1. Companion Animals
            7.3.1.1. Dog
            7.3.1.2. Cat
        7.3.2. Livestock
            7.3.2.1. Cattle
            7.3.2.2. Horse
            7.3.2.3. Sheep
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031
        8.3.1. Joint Health Support
        8.3.2. Calming/Stress/Anxiety
        8.3.3. Digestive Health
        8.3.4. Energy & Electrolytes
        8.3.5. Immunity Support
        8.3.6. Skin & Coat Health
        8.3.7. Others
    8.4. Market Attractiveness Analysis, by Application/Benefit Area
9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by Dosage Form, 2017-2031
        9.3.1. Pills & Tablets
        9.3.2. Chewables
        9.3.3. Powders
        9.3.4. Others
    9.4. Market Attractiveness Analysis, by Dosage Form
10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel
    10.1. Introduction & Definition
    10.2. Key Findings/Developments
    10.3. Market Value Forecast, by Distribution Channel, 2017-2031
        10.3.1. Small Animal Veterinary
        10.3.2. Large Animal Veterinary
        10.3.3. Mixed Animal Veterinary
        10.3.4. Retail Stores
        10.3.5. Drug Stores
        10.3.6. Online Sales
    10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Veterinary Supplements Market Analysis and Forecast, by Region
    11.1. Key Findings
    11.2. Market Value Forecast, by Region, 2017-2031
        11.2.1. North America
        11.2.2. Europe
        11.2.3. Asia Pacific
        11.2.4. Latin America
        11.2.5. Middle East & Africa
    11.3. Market Attractiveness Analysis, by Region
12. North America Veterinary Supplements Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Supplement Type, 2017-2031
        12.2.1. Antioxidants
        12.2.2. Vitamins
        12.2.3. Proteins/Amino acids
        12.2.4. Enzymes
        12.2.5. Probiotics
        12.2.6. Essential Fatty Acids
        12.2.7. Others
    12.3. Market Value Forecast, by Animal Type, 2017-2031
        12.3.1. Companion Animals
            12.3.1.1. Dog
            12.3.1.2. Cat
        12.3.2. Livestock
            12.3.2.1. Cattle
            12.3.2.2. Horse
            12.3.2.3. Sheep
        12.3.3. Others
    12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        12.4.1. Joint Health Support
        12.4.2. Calming/Stress/Anxiety
        12.4.3. Digestive Health
        12.4.4. Energy & Electrolytes
        12.4.5. Immunity Support
        12.4.6. Skin & Coat Health
        12.4.7. Others
    12.5. Market Value Forecast, by Dosage Form, 2017-2031
        12.5.1. Pills & Tablets
        12.5.2. Chewables
        12.5.3. Powders
        12.5.4. Others
    12.6. Market Value Forecast, by Distribution Channel, 2017-2031
        12.6.1. Small Animal Veterinary
        12.6.2. Large Animal Veterinary
        12.6.3. Mixed Animal Veterinary
        12.6.4. Retail Stores
        12.6.5. Drug Stores
        12.6.6. Online Sales
    12.7. Market Value Forecast, by Country, 2017-2031
        12.7.1. U.S.
        12.7.2. Canada
    12.8. Market Attractiveness Analysis
        12.8.1. By Supplement Type
        12.8.2. By Animal Type
        12.8.3. By Application/Benefit Area
        12.8.4. By Dosage Form
        12.8.5. By Distribution Channel
        12.8.6. By Country
13. Europe Veterinary Supplements Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Supplement Type, 2017-2031
        13.2.1. Antioxidants
        13.2.2. Vitamins
        13.2.3. Proteins/Amino acids
        13.2.4. Enzymes
        13.2.5. Probiotics
        13.2.6. Essential Fatty Acids
        13.2.7. Others
    13.3. Market Value Forecast, by Animal Type, 2017-2031
        13.3.1. Companion Animals
            13.3.1.1. Dog
            13.3.1.2. Cat
        13.3.2. Livestock
            13.3.2.1. Cattle
            13.3.2.2. Horse
            13.3.2.3. Sheep
        13.3.3. Others
    13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        13.4.1. Joint Health Support
        13.4.2. Calming/Stress/Anxiety
        13.4.3. Digestive Health
        13.4.4. Energy & Electrolytes
        13.4.5. Immunity Support
        13.4.6. Skin & Coat Health
        13.4.7. Others
    13.5. Market Value Forecast, by Dosage Form, 2017-2031
        13.5.1. Pills & Tablets
        13.5.2. Chewables
        13.5.3. Powders
        13.5.4. Others
    13.6. Market Value Forecast, by Distribution Channel, 2017-2031
        13.6.1. Small Animal Veterinary
        13.6.2. Large Animal Veterinary
        13.6.3. Mixed Animal Veterinary
        13.6.4. Retail Stores
        13.6.5. Drug Stores
        13.6.6. Online Sales
    13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.7.1. Germany
        13.7.2. U.K.
        13.7.3. France
        13.7.4. Italy
        13.7.5. Spain
        13.7.6. Rest of Europe
    13.8. Market Attractiveness Analysis
        13.8.1. By Supplement Type
        13.8.2. By Animal Type
        13.8.3. By Application/Benefit Area
        13.8.4. By Dosage Form
        13.8.5. By Distribution Channel
        13.8.6. By Country/Sub-region
14. Asia Pacific Veterinary Supplements Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Supplement Type, 2017-2031
        14.2.1. Antioxidants
        14.2.2. Vitamins
        14.2.3. Proteins/Amino acids
        14.2.4. Enzymes
        14.2.5. Probiotics
        14.2.6. Essential Fatty Acids
        14.2.7. Others
    14.3. Market Value Forecast, by Animal Type, 2017-2031
        14.3.1. Companion Animals
            14.3.1.1. Dog
            14.3.1.2. Cat
        14.3.2. Livestock
            14.3.2.1. Cattle
            14.3.2.2. Horse
            14.3.2.3. Sheep
        14.3.3. Others
    14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        14.4.1. Joint Health Support
        14.4.2. Calming/Stress/Anxiety
        14.4.3. Digestive Health
        14.4.4. Energy & Electrolytes
        14.4.5. Immunity Support
        14.4.6. Skin & Coat Health
        14.4.7. Others
    14.5. Market Value Forecast, by Dosage Form, 2017-2031
        14.5.1. Pills & Tablets
        14.5.2. Chewables
        14.5.3. Powders
        14.5.4. Others
    14.6. Market Value Forecast, by Distribution Channel, 2017-2031
        14.6.1. Small Animal Veterinary
        14.6.2. Large Animal Veterinary
        14.6.3. Mixed Animal Veterinary
        14.6.4. Retail Stores
        14.6.5. Drug Stores
        14.6.6. Online Sales
    14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.7.1. China
        14.7.2. Japan
        14.7.3. India
        14.7.4. Australia & New Zealand
        14.7.5. Rest of Asia Pacific
    14.8. Market Attractiveness Analysis
        14.8.1. By Supplement Type
        14.8.2. By Animal Type
        14.8.3. By Application/Benefit Area
        14.8.4. By Dosage Form
        14.8.5. By Distribution Channel
        14.8.6. By Country/Sub-region
15. Latin America Veterinary Supplements Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Supplement Type, 2017-2031
        15.2.1. Antioxidants
        15.2.2. Vitamins
        15.2.3. Proteins/Amino acids
        15.2.4. Enzymes
        15.2.5. Probiotics
        15.2.6. Essential Fatty Acids
        15.2.7. Others
    15.3. Market Value Forecast, by Animal Type, 2017-2031
        15.3.1. Companion Animals
            15.3.1.1. Dog
            15.3.1.2. Cat
        15.3.2. Livestock
            15.3.2.1. Cattle
            15.3.2.2. Horse
            15.3.2.3. Sheep
        15.3.3. Others
    15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        15.4.1. Joint Health Support
        15.4.2. Calming/Stress/Anxiety
        15.4.3. Digestive Health
        15.4.4. Energy & Electrolytes
        15.4.5. Immunity Support
        15.4.6. Skin & Coat Health
        15.4.7. Others
    15.5. Market Value Forecast, by Dosage Form, 2017-2031
        15.5.1. Pills & Tablets
        15.5.2. Chewables
        15.5.3. Powders
        15.5.4. Others
    15.6. Market Value Forecast, by Distribution Channel, 2017-2031
        15.6.1. Small Animal Veterinary
        15.6.2. Large Animal Veterinary
        15.6.3. Mixed Animal Veterinary
        15.6.4. Retail Stores
        15.6.5. Drug Stores
        15.6.6. Online Sales
    15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.7.1. Brazil
        15.7.2. Mexico
        15.7.3. Rest of Latin America
    15.8. Market Attractiveness Analysis
        15.8.1. By Supplement Type
        15.8.2. By Animal Type
        15.8.3. By Application/Benefit Area
        15.8.4. By Dosage Form
        15.8.5. By Distribution Channel
        15.8.6. By Country/Sub-region
16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast
    16.1. Introduction
        16.1.1. Key Findings
    16.2. Market Value Forecast, by Supplement Type, 2017-2031
        16.2.1. Antioxidants
        16.2.2. Vitamins
        16.2.3. Proteins/Amino acids
        16.2.4. Enzymes
        16.2.5. Probiotics
        16.2.6. Essential Fatty Acids
        16.2.7. Others
    16.3. Market Value Forecast, by Animal Type, 2017-2031
        16.3.1. Companion Animals
            16.3.1.1. Dog
            16.3.1.2. Cat
        16.3.2. Livestock
            16.3.2.1. Cattle
            16.3.2.2. Horse
            16.3.2.3. Sheep
        16.3.3. Others
    16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
        16.4.1. Joint Health Support
        16.4.2. Calming/Stress/Anxiety
        16.4.3. Digestive Health
        16.4.4. Energy & Electrolytes
        16.4.5. Immunity Support
        16.4.6. Skin & Coat Health
        16.4.7. Others
    16.5. Market Value Forecast, by Dosage Form, 2017-2031
        16.5.1. Pills & Tablets
        16.5.2. Chewables
        16.5.3. Powders
        16.5.4. Others
    16.6. Market Value Forecast, by Distribution Channel, 2017-2031
        16.6.1. Small Animal Veterinary
        16.6.2. Large Animal Veterinary
        16.6.3. Mixed Animal Veterinary
        16.6.4. Retail Stores
        16.6.5. Drug Stores
        16.6.6. Online Sales
    16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
        16.7.1. GCC Countries
        16.7.2. South Africa
        16.7.3. Rest of Middle East & Africa
    16.8. Market Attractiveness Analysis
        16.8.1. By Supplement Type
        16.8.2. By Animal Type
        16.8.3. By Application/Benefit Area
        16.8.4. By Dosage Form
        16.8.5. By Distribution Channel
        16.8.6. By Country/Sub-region
17. Competition Landscape
    17.1. Market Player - Competition Matrix (by tier and size of companies)
    17.2. Market Share Analysis, by Company, 2022
    17.3. Company Profiles
        17.3.1. Zoetis
            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.1.2. Product Portfolio
            17.3.1.3. Financial Overview
            17.3.1.4. SWOT Analysis
            17.3.1.5. Strategic Overview
        17.3.2. Ceva Sante Animale
            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2.2. Product Portfolio
            17.3.2.3. Financial Overview
            17.3.2.4. SWOT Analysis
            17.3.2.5. Strategic Overview
        17.3.3. Elanco Animal Health
            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.3.2. Product Portfolio
            17.3.3.3. Financial Overview
            17.3.3.4. SWOT Analysis
            17.3.3.5. Strategic Overview
        17.3.4. Vetoquinol S.A.
            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.4.2. Product Portfolio
            17.3.4.3. Financial Overview
            17.3.4.4. SWOT Analysis
            17.3.4.5. Strategic Overview
        17.3.5. Dechra Pharmaceuticals plc
            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.5.2. Product Portfolio
            17.3.5.3. Financial Overview
            17.3.5.4. SWOT Analysis
            17.3.5.5. Strategic Overview
        17.3.6. Merck Animal Health
            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.6.2. Product Portfolio
            17.3.6.3. Financial Overview
            17.3.6.4. SWOT Analysis
            17.3.6.5. Strategic Overview
        17.3.7. Virbac S.A.
            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.7.2. Product Portfolio
            17.3.7.3. Financial Overview
            17.3.7.4. SWOT Analysis
            17.3.7.5. Strategic Overview
        17.3.8. Boehringer Ingelheim
            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.8.2. Product Portfolio
            17.3.8.3. Financial Overview
            17.3.8.4. SWOT Analysis
            17.3.8.5. Strategic Overview
        17.3.9. Norbrook Laboratories Limited
            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.9.2. Product Portfolio
            17.3.9.3. Financial Overview
            17.3.9.4. SWOT Analysis
            17.3.9.5. Strategic Overview
        17.3.10. Hester Biosciences Limited
            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.10.2. Product Portfolio
            17.3.10.3. Financial Overview
            17.3.10.4. SWOT Analysis
            17.3.10.5. Strategic Overview
        17.3.11. Merial Animal Health Limited
            17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.11.2. Product Portfolio
            17.3.11.3. Financial Overview
            17.3.11.4. SWOT Analysis
            17.3.11.5. Strategic Overview
        17.3.12. Novartis Animal Health, Inc.
            17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.12.2. Product Portfolio
            17.3.12.3. Financial Overview
            17.3.12.4. SWOT Analysis
            17.3.12.5. Strategic Overview
        17.3.13. Nutreco N.V.
            17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.13.2. Product Portfolio
            17.3.13.3. Financial Overview
            17.3.13.4. SWOT Analysis
            17.3.13.5. Strategic Overview
        17.3.14. Ouro Fino Saúde Animal
            17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.14.2. Product Portfolio
            17.3.14.3. Financial Overview
            17.3.14.4. SWOT Analysis
            17.3.14.5. Strategic Overview

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Transparency Market Research社の製薬分野での最新刊レポート

本レポートと同じKEY WORD(enzymes)の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る